Edwards Lifesciences (EW) Shares Outstanding (2010 - 2026)

Edwards Lifesciences' Shares Outstanding history runs 17 years deep, the most recent figure standing at $660.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 0.63% year-over-year to $660.0 million; the TTM figure through Mar 2026 stood at $660.0 million (up 0.63% YoY), while the FY2025 annual figure was $580.7 million, down 11.32% from the prior year.
• Shares Outstanding was $660.0 million for Q1 2026 at Edwards Lifesciences, up from $580.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $660.0 million in Q1 2026 to a low of $580.7 million in Q3 2025.
• Historically, Shares Outstanding has averaged $642.7 million across 5 years, with a median of $649.9 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding grew 0.85% in 2022, then declined 11.32% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $646.3 million in 2022, then advanced by 0.65% to $650.5 million in 2023, then rose by 0.66% to $654.8 million in 2024, then fell by 11.32% to $580.7 million in 2025, then rose by 13.66% to $660.0 million in 2026.
• The last three Shares Outstanding figures came in at $660.0 million (Q1 2026), $580.7 million (Q4 2025), and $580.7 million (Q3 2025), per Business Quant data.